Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs

Research output: Contribution to journalReview article

61 Citations (Scopus)

Abstract

This review evaluates drug delivery systems that involve intact plasma lipoproteins or some of their components. These complex macromolecules transport highly water-insoluble compounds (cholesteryl esters and triacylglycerols) in their natural environment - a property that renders them ideal carriers of hydrophobic drugs. Particular emphasis is placed on the application of lipoproteins as drug delivery agents in cancer chemotherapy. The history and present activity regarding lipoprotein-based formulations are reviewed, with the primary focus on the smaller sized (low and high density) lipoprotein-based formulations and their potential clinical and commercial value. The use of both native and synthetic lipoproteins as drug delivery agents are discussed from the standpoint of therapeutic efficacy, as well as commercial feasibility. The advantages of lipoprotein-based drug delivery formulations are compared with other drug delivery models, with the primary focus on liposomal preparations. Finally, an expert opinion is provided, regarding the potential use of lipoprotein-based formulations in cancer treatment, taking into consideration the major advantages (biocompatibility, safety, drug solubility) and the barriers (manufacturing protein components, financial interest, investments) to their commercial development.

Original languageEnglish
Pages (from-to)665-675
Number of pages11
JournalExpert Opinion on Drug Delivery
Volume4
Issue number6
DOIs
StatePublished - 1 Nov 2007

Fingerprint

Lipoproteins
Pharmaceutical Preparations
Neoplasms
Drug Compounding
Drug Carriers
Cholesterol Esters
Expert Testimony
HDL Lipoproteins
Drug Delivery Systems
LDL Lipoproteins
Antineoplastic Agents
Solubility
Triglycerides
History
Safety
Water
Therapeutics
Proteins

Keywords

  • Cancer chemotherapy
  • Drug delivery
  • Lipoprotein
  • Targeting

Cite this

@article{db8571d2d1a844058a8cd34e45efc78c,
title = "Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs",
abstract = "This review evaluates drug delivery systems that involve intact plasma lipoproteins or some of their components. These complex macromolecules transport highly water-insoluble compounds (cholesteryl esters and triacylglycerols) in their natural environment - a property that renders them ideal carriers of hydrophobic drugs. Particular emphasis is placed on the application of lipoproteins as drug delivery agents in cancer chemotherapy. The history and present activity regarding lipoprotein-based formulations are reviewed, with the primary focus on the smaller sized (low and high density) lipoprotein-based formulations and their potential clinical and commercial value. The use of both native and synthetic lipoproteins as drug delivery agents are discussed from the standpoint of therapeutic efficacy, as well as commercial feasibility. The advantages of lipoprotein-based drug delivery formulations are compared with other drug delivery models, with the primary focus on liposomal preparations. Finally, an expert opinion is provided, regarding the potential use of lipoprotein-based formulations in cancer treatment, taking into consideration the major advantages (biocompatibility, safety, drug solubility) and the barriers (manufacturing protein components, financial interest, investments) to their commercial development.",
keywords = "Cancer chemotherapy, Drug delivery, Lipoprotein, Targeting",
author = "Lacko, {Andras G.} and Nair, {Maya P.} and Laszlo Prokai and McConarthy, {Walter J.}",
year = "2007",
month = "11",
day = "1",
doi = "10.1517/17425247.4.6.665",
language = "English",
volume = "4",
pages = "665--675",
journal = "Expert Opinion on Drug Delivery",
issn = "1742-5247",
publisher = "Taylor and Francis Ltd.",
number = "6",

}

Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs. / Lacko, Andras G.; Nair, Maya P.; Prokai, Laszlo; McConarthy, Walter J.

In: Expert Opinion on Drug Delivery, Vol. 4, No. 6, 01.11.2007, p. 665-675.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs

AU - Lacko, Andras G.

AU - Nair, Maya P.

AU - Prokai, Laszlo

AU - McConarthy, Walter J.

PY - 2007/11/1

Y1 - 2007/11/1

N2 - This review evaluates drug delivery systems that involve intact plasma lipoproteins or some of their components. These complex macromolecules transport highly water-insoluble compounds (cholesteryl esters and triacylglycerols) in their natural environment - a property that renders them ideal carriers of hydrophobic drugs. Particular emphasis is placed on the application of lipoproteins as drug delivery agents in cancer chemotherapy. The history and present activity regarding lipoprotein-based formulations are reviewed, with the primary focus on the smaller sized (low and high density) lipoprotein-based formulations and their potential clinical and commercial value. The use of both native and synthetic lipoproteins as drug delivery agents are discussed from the standpoint of therapeutic efficacy, as well as commercial feasibility. The advantages of lipoprotein-based drug delivery formulations are compared with other drug delivery models, with the primary focus on liposomal preparations. Finally, an expert opinion is provided, regarding the potential use of lipoprotein-based formulations in cancer treatment, taking into consideration the major advantages (biocompatibility, safety, drug solubility) and the barriers (manufacturing protein components, financial interest, investments) to their commercial development.

AB - This review evaluates drug delivery systems that involve intact plasma lipoproteins or some of their components. These complex macromolecules transport highly water-insoluble compounds (cholesteryl esters and triacylglycerols) in their natural environment - a property that renders them ideal carriers of hydrophobic drugs. Particular emphasis is placed on the application of lipoproteins as drug delivery agents in cancer chemotherapy. The history and present activity regarding lipoprotein-based formulations are reviewed, with the primary focus on the smaller sized (low and high density) lipoprotein-based formulations and their potential clinical and commercial value. The use of both native and synthetic lipoproteins as drug delivery agents are discussed from the standpoint of therapeutic efficacy, as well as commercial feasibility. The advantages of lipoprotein-based drug delivery formulations are compared with other drug delivery models, with the primary focus on liposomal preparations. Finally, an expert opinion is provided, regarding the potential use of lipoprotein-based formulations in cancer treatment, taking into consideration the major advantages (biocompatibility, safety, drug solubility) and the barriers (manufacturing protein components, financial interest, investments) to their commercial development.

KW - Cancer chemotherapy

KW - Drug delivery

KW - Lipoprotein

KW - Targeting

UR - http://www.scopus.com/inward/record.url?scp=36649031633&partnerID=8YFLogxK

U2 - 10.1517/17425247.4.6.665

DO - 10.1517/17425247.4.6.665

M3 - Review article

C2 - 17970668

AN - SCOPUS:36649031633

VL - 4

SP - 665

EP - 675

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

SN - 1742-5247

IS - 6

ER -